Skip to main content

Year: 2024

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected in the first half of 2025 Nominated novel portfolio of preclinical ophthalmology product candidates to R&D pipeline Received $10 million milestone payment from Boehringer Ingelheim strategic collaboration on SZN-413 in retinal vascular associated diseases SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today provided third quarter 2024 financial results and business updates. “In the third quarter, we made substantial progress on enrolling patients in the SZN-043 Phase 1b trial, received notification...

Continue reading

Mama’s Creations to Attend Upcoming Winter Investor Conferences

Written by Customer Service on . Posted in Public Companies.

EAST RUTHERFORD, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, today announced that management will attend the Raymond James Small Cap Summit, the 15th Annual Craig-Hallum Alpha Select Conference, and the 13th Annual ROTH Deer Valley Event in Winter 2024. Adam L. Michaels, Chairman and CEO of Mama’s Creations, is scheduled to host one-on-one meetings with institutional investors at each event. Raymond James Small Cap SummitDate: Monday, November 18, 2024Location: Sonoma, CAFormat: 1x1s Meetings Only 15th Annual Craig-Hallum Alpha Select ConferenceDate: Tuesday, November 19, 2024Location: New York, NYFormat: 1x1s Meetings Only 13th Annual ROTH Deer Valley EventDate: December 11-14, 2024Location: Park City, UTFormat: 1×1...

Continue reading

Reborn Coffee Closes Acquisition of 58% Stake in South Korea’s Bbang Ssaem Bakery

Written by Customer Service on . Posted in Mergers And Acquisitions.

Strategic Acquisition Bringing Reborn Coffee’s High-End Café Concept Together with Bbang Ssaem’s Bakery Expertise to Drive Revenue and Growth BREA, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) — Reborn Coffee, Inc. (NASDAQ: REBN), a premier specialty coffee retailer, is pleased to announce the successful acquisition of a 58% stake in Bbang Ssaem Bakery, a leading bakery chain with 31 locations across South Korea. This acquisition follows the previously signed MOU between the two companies, solidifying Reborn Coffee’s commitment to expanding its offerings and establishing a strong presence in the bakery sector. Bbang Ssaem’s established presence in the Korean market, combined with Reborn Coffee’s specialty coffee expertise, creates a unique opportunity to enhance brand strength. This acquisition also serves as a launchpad...

Continue reading

Zeo Energy Corp. and Lumio Complete Sale Transaction

Written by Customer Service on . Posted in Mergers And Acquisitions.

Zeo Energy Acquires Substantially All of Lumio’s Assets Transaction is Expected to Position Zeo Energy for Enhanced Market Presence and Expansion NEW PORT RICHEY, Fla. and LEHI, Utah, Nov. 06, 2024 (GLOBE NEWSWIRE) — Zeo Energy Corp. (Nasdaq: ZEO) ( “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that it has completed the acquisition of substantially all of the assets (the “Sale Transaction”) of Lumio Holdings, Inc. (“Lumio”), another residential solar company. On September 3, 2024, Lumio filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (“the Court”). The Sale Transaction was approved by the Court on November 1, 2024. Tim Bridgewater, CEO of Zeo...

Continue reading

CORRECTION: Cellebrite Announces Third-Quarter 2024 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline on Wednesday, November 6th by Cellebrite (NASDAQ: CLBT), please note that the dial-in number was corrected. The corrected release follows: Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public...

Continue reading

Greystone Housing Impact Investors Reports Third Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

OMAHA, Neb., Nov. 06, 2024 (GLOBE NEWSWIRE) — On November 6, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three and nine months ended September 30, 2024. Financial Highlights The Partnership reported the following results as of and for the three months ended September 30, 2024:Net loss of $0.23 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $0.27 per BUC Total assets of $1.55 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.24 billionThe difference between reported net income per BUC and CAD per BUC is primarily due to the treatment of unrealized losses on the Partnership’s interest rate derivative positions. Unrealized losses of approximately $9.7 million...

Continue reading

Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference

Written by Customer Service on . Posted in Public Companies.

Live fireside chat with CEO, Russ Trenary, on November 12th at 2:30 PM ET ISELIN, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Russell Trenary, President and CEO of Outlook Therapeutics will participate in a fireside chat on Tuesday, November 12, 2024 at 2:30 PM ET at the Guggenheim Healthcare Innovation Conference being held in Boston, MA. In addition to the fireside chat, management will be available to participate in one-on-one in-person meetings with qualified members of the investor community who are registered...

Continue reading

One Stop Systems Announces Chief Financial Officer Transition

Written by Customer Service on . Posted in Public Companies.

Daniel Gabel Appointed Chief Financial Officer, Treasurer and SecretaryESCONDIDO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced Daniel Gabel has been appointed CFO, Treasurer, and Secretary, effective November 11, 2024. Gabel will succeed John Morrison, who has announced his retirement from OSS. Morrison has served as the Company’s CFO, Treasurer, and Secretary since September 2017 and will remain with the Company as a non-executive employee from November 11, 2024, until November 30, 2024, to ensure a seamless transition. “I want to thank John for his commitment and dedication to OSS. John has played a key role in developing...

Continue reading

CMC Metals Announces Results of AGM and Granting of Options

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — CMC Metals Ltd. (TSX-V: CMB) (Frankfurt:ZM5N) (“CMC” or the “Company”) is pleased to announce the results of its 2024 Annual and Special General Meeting (“AGM”) of shareholders held on September 25, 2024. Shareholders approved all the resolutions detailed in the management information circular of the Company (the “Circular”), namely:Electing all the nominees to the Board of Directors of the Company. Appointing Manning Elliott LLP as auditor of the Company for the ensuing year and authorizing the directors to determine the auditor’s compensation. Approving the Incentive Stock Option Plan for the Company.A total of 10,493,653 common shares of the Company were voted at the AGM, representing approximately 6.65% of the issued and outstanding common shares of the Company,...

Continue reading

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

Written by Customer Service on . Posted in Public Companies.

WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that management will participate in a fireside chat and 1×1 investor meetings at the Guggenheim Securities Healthcare Innovation Conference taking place November 11-13, 2024. Fireside Chat: Wednesday, November 13, 2024 at 2:30 PM ET Location: Boston, MA The live webcast link will be available in the investor section of the company’s website at https://investors.invivyd.com and will be archived for approximately 30 days following the event. About InvivydInvivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.